DiscoverJAMA Clinical ReviewsCAR T Cells and T-Cell Therapies for Cancer
CAR T Cells and T-Cell Therapies for Cancer

CAR T Cells and T-Cell Therapies for Cancer

Update: 2024-11-04
Share

Description

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.”

Related Content:

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

CAR T Cells and T-Cell Therapies for Cancer

CAR T Cells and T-Cell Therapies for Cancer